InVivo Therapeutics Holdings Corporation carries a market capitalization of 995,918.00, placing it among publicly traded companies globally.
| Market Cap | 995,918.00 |
| Enterprise Value | N/A |
InVivo Therapeutics Holdings Corporation's stock has declined approximately -67.93% over the past 52 weeks. The 50-day moving average sits at 0.70, while the 200-day moving average is 1.05.
| Beta (5Y) | N/A |
| 52-Week Price Change | -67.93% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 1.05 |
| Average Volume (20 Days) | N/A |
InVivo Therapeutics Holdings Corporation's most recent stock split took place on April 27, 2022 with a 25:1 split ratio.
| Last Split Date | 4/27/2022 |
| Split Ratio | 25:1 |